Alternative Antibiotics for Ceftriaxone Allergy in Elderly Patients

Introduction to Alternative Antibiotics

The American College of Cardiology and other guideline societies recommend fluoroquinolones, such as levofloxacin or ciprofloxacin, as alternative antibiotics for elderly patients with ceftriaxone allergy, with careful attention to renal dosing and monitoring for neuropsychiatric adverse effects 1

For urinary tract infections, the Infectious Diseases Society of America recommends levofloxacin 750 mg orally once daily for 5-7 days, providing optimal coverage with bacteriologic cure rates of 80-85% 1
For respiratory or systemic infections, fluoroquinolones, such as levofloxacin or moxifloxacin, provide broad-spectrum coverage 2
Vancomycin is reasonable for gram-positive coverage if beta-lactams cannot be used, according to the Clinical Infectious Diseases society 3, 4
Aztreonam can be considered for gram-negative coverage in patients with severe beta-lactam allergy, as it has minimal cross-reactivity, as stated by the Clinical Infectious Diseases society 3

Calculate creatinine clearance using the Cockcroft-Gault equation, rather than relying on serum creatinine alone, as this is more accurate in elderly patients, according to Praxis Medical Insights 5, 6

Assess clinical response within 72 hours and consider alternative therapy if no improvement, as recommended by Praxis Medical Insights 1
Monitor for confusion, functional decline, or falls, which may indicate drug toxicity in elderly patients, according to Praxis Medical Insights 1

Vancomycin can be used for gram-positive coverage, requiring therapeutic drug monitoring and renal dose adjustment, as recommended by the Clinical Infectious Diseases society 3, 4
Aztreonam can be used for gram-negative coverage, with minimal cross-reactivity with beta-lactams, according to the Clinical Infectious Diseases society 3
Aminoglycosides, such as gentamicin or tobramycin, can be used in combination therapy, though with caution due to nephrotoxicity and ototoxicity risks in elderly patients with baseline renal impairment, as stated by the Clinical Infectious Diseases society 3, 7

The American Thoracic Society recommends obtaining a baseline ECG before initiating moxifloxacin and repeating at 2 weeks, as QT prolongation is a serious risk, particularly in elderly patients 8
Moxifloxacin should not be used in patients with congenital or acquired QT prolongation, clinically relevant bradycardia, heart failure with reduced ejection fraction, history of symptomatic arrhythmias, or uncorrected electrolyte disturbances, according to the Thorax journal 8
Avoid concurrent use with drugs that prolong the QT interval, including class IA and III antiarrhythmics, tricyclic antidepressants, macrolides, and antipsychotics, as recommended by the Thorax journal 8

The standard adult dose of moxifloxacin is 400 mg once daily, with no adjustment needed for renal impairment, as stated in the Thorax journal 8

Monitor blood glucose regularly if the patient has diabetes, as moxifloxacin carries a risk of hypoglycemia in patients on hypoglycemic drugs, according to the Thorax journal 8